1 January 2022 in Infection & Chemotherapy
Sanyaolu A, et al. Infect Chemother. 2022 Jun;54:e44. https://doi.org/10.3947/ic.2022.0008
25 July 2020 in SN Comprehensive Clinical Medicine
The recent outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in Hubei province, China, in December 2019 and has spread worldwide at an alarming rate. With over eight million individuals infected and exceeding 400,000 deaths globally, the necessity to develop fast and efficient diagnostic methods is of high importance. This paper reports on currently available diagnostic screening methods for patients infected with SARS-CoV-2 to guide frontline healthcare workers involved with the diagnosis of 2019 novel coronavirus disease (COVID-19) patient. An electronic literature search was performed for peer-reviewed articles published from January 1, 2020, until June 19, 2020. Published articles were then reviewed and included based on the applicability to the topic. The preferred diagnostic approach is the reverse transcription (RT) of the virus’ ribonucleic acid (RNA) followed by polymerase chain reaction (PCR) amplification (RT-PCR). However, this method has been proven to be time-consuming. In improving the speed and efficiency of diagnostics, newer rapid diagnostic serological tests are in development for testing SARS-CoV-2, each with its unique advantages and disadvantages. They could potentially be used as triage tests to rapidly identify patients who are very likely to have COVID-19 in combination with other accurate diagnostic methods, such as diagnostic imaging. A combination of the disease history, clinical manifestations, laboratory diagnostic testing, and diagnostic imaging is crucial for making an accurate and useful diagnosis for COVID-19. Hopefully, the continuous development and use of rapid diagnostic tests and the implementation of public health measures will help control the spread of the disease.
1 January 2022 in Clinical and Experimental Vaccine Research
Sanyaolu A, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):104-115. https://doi.org/10.7774/cevr.2022.11.1.104
1 January 2025 in Case Reports in Gastrointestinal Medicine
Neuroendocrine tumors (NETs) are rare neoplasms composed of neuroendocrine cells and seen in approximately 2% of malignancies in the United States. These are often underdiagnosed due to nonspecific presentations early in the disease course. Although found primarily in the gastrointestinal tract, lungs, and pancreas, these tumors can be seen anywhere in the body. The following case highlights an unusual presentation of a NET and subsequent management of hepatic hydrothorax in the setting of obstruction rather than decompensated liver cirrhosis.